Kaye, K., File, T., Boucher, H. W., Brown, M., Aggrey, A., Khan, I., Joeng, H., Tipping, R., Du, J., Young, K., Butterton, J., Kartsonis, N. A., & Paschke, A. (n.d.). 1339. Results for the Supplemental Microbiological Modified Intent-to-Treat (SmMITT) Population of the RESTORE-IMI 1 Trial of Imipenem/Cilastatin/Relebactam (IMI/REL) vs. Imipenem/Cilastatin Plus Colistin (IMI+CST) in Patients with Imipenem-Nonsusceptible (NS) Bacterial Infections. Open forum infectious diseases, 5, S409. http://access.bl.uk/ark:/81055/vdc_100095535500.0x000007